Diagnostic and therapeutic approach to the ACS patient
The current management strategy of acute coronary syndromes aims at symptoms relief as well as at specifically antagonizing each of the different pathogenic components of myocardial ischemia, including the pro-thrombotic state, poor coronary flow and myocardial damage. Different approaches are available, including revascularization procedures and pharmacological interventions. Various anti-anginal, anti-thrombotic and anti-coagulant drugs can be used according to individual features and needs, as well as secondary prevention measures based on statin use and ACE-inhibition. The appropriate use of available measures is crucial to reduce mortality and improve long-term prognosis in patients with acute coronary syndromes..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Global & Regional Health Technology Assessment - 9(2022), Suppl. 1 |
| Sprache: |
Englisch ; Spanisch ; Italienisch |
|---|
| Beteiligte Personen: |
Fabrizio Ricci [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Acute coronary syndrome |
|---|
| doi: |
10.33393/grhta.2022.2389 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ022319573 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ022319573 | ||
| 003 | DE-627 | ||
| 005 | 20230503150550.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.33393/grhta.2022.2389 |2 doi | |
| 035 | |a (DE-627)DOAJ022319573 | ||
| 035 | |a (DE-599)DOAJ33319e69d6624216995843af56ebba04 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a spa |a ita | ||
| 050 | 0 | |a R855-855.5 | |
| 100 | 0 | |a Fabrizio Ricci |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Diagnostic and therapeutic approach to the ACS patient |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The current management strategy of acute coronary syndromes aims at symptoms relief as well as at specifically antagonizing each of the different pathogenic components of myocardial ischemia, including the pro-thrombotic state, poor coronary flow and myocardial damage. Different approaches are available, including revascularization procedures and pharmacological interventions. Various anti-anginal, anti-thrombotic and anti-coagulant drugs can be used according to individual features and needs, as well as secondary prevention measures based on statin use and ACE-inhibition. The appropriate use of available measures is crucial to reduce mortality and improve long-term prognosis in patients with acute coronary syndromes. | ||
| 650 | 4 | |a Acute coronary syndrome | |
| 650 | 4 | |a Diagnostic approach | |
| 650 | 4 | |a Revascularization | |
| 650 | 4 | |a Treatment | |
| 653 | 0 | |a Medical technology | |
| 700 | 0 | |a Federico Archilletti |e verfasserin |4 aut | |
| 700 | 0 | |a Raffaele De Caterina |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Global & Regional Health Technology Assessment |d AboutScience Srl, 2017 |g 9(2022), Suppl. 1 |w (DE-627)DOAJ000020729 |x 22835733 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2022 |g number:Suppl. 1 |
| 856 | 4 | 0 | |u https://doi.org/10.33393/grhta.2022.2389 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/33319e69d6624216995843af56ebba04 |z kostenfrei |
| 856 | 4 | 0 | |u https://journals.aboutscience.eu/index.php/grhta/article/view/2389 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2284-2403 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2283-5733 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2022 |e Suppl. 1 | ||